The DNA damage response and cancer therapy - PubMed (original) (raw)

Review

. 2012 Jan 18;481(7381):287-94.

doi: 10.1038/nature10760.

Affiliations

• PMID: 22258607
• DOI: 10.1038/nature10760

Review

The DNA damage response and cancer therapy

Christopher J Lord et al. Nature. 2012.

Abstract

Genomic instability is one of the most pervasive characteristics of tumour cells and is probably the combined effect of DNA damage, tumour-specific DNA repair defects, and a failure to stop or stall the cell cycle before the damaged DNA is passed on to daughter cells. Although these processes drive genomic instability and ultimately the disease process, they also provide therapeutic opportunities. A better understanding of the cellular response to DNA damage will not only inform our knowledge of cancer development but also help to refine the classification as well as the treatment of the disease.

PubMed Disclaimer

Similar articles

• PARP Inhibitors in Clinical Use Induce Genomic Instability in Normal Human Cells.
  Ito S, Murphy CG, Doubrovina E, Jasin M, Moynahan ME. Ito S, et al. PLoS One. 2016 Jul 18;11(7):e0159341. doi: 10.1371/journal.pone.0159341. eCollection 2016. PLoS One. 2016. PMID: 27428646 Free PMC article.
• Poly-ADP-ribose polymerases (PARPs) as a therapeutic target in the treatment of selected cancers.
  Przybycinski J, Nalewajska M, Marchelek-Mysliwiec M, Dziedziejko V, Pawlik A. Przybycinski J, et al. Expert Opin Ther Targets. 2019 Sep;23(9):773-785. doi: 10.1080/14728222.2019.1654458. Epub 2019 Aug 13. Expert Opin Ther Targets. 2019. PMID: 31394942 Review.
• Strategies for targeting the DNA damage response for cancer therapeutics.
  Zhang D, Wang HB, Brinkman KL, Han SX, Xu B. Zhang D, et al. Chin J Cancer. 2012 Aug;31(8):359-63. doi: 10.5732/cjc.012.10087. Epub 2012 Jun 14. Chin J Cancer. 2012. PMID: 22704491 Free PMC article. Review.
• The lysine-specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer.
  Rampias T, Karagiannis D, Avgeris M, Polyzos A, Kokkalis A, Kanaki Z, Kousidou E, Tzetis M, Kanavakis E, Stravodimos K, Manola KN, Pantelias GE, Scorilas A, Klinakis A. Rampias T, et al. EMBO Rep. 2019 Mar;20(3):e46821. doi: 10.15252/embr.201846821. Epub 2019 Jan 21. EMBO Rep. 2019. PMID: 30665945 Free PMC article.
• DNA Damage Repair and the Emerging Role of Poly(ADP-ribose) Polymerase Inhibition in Cancer Therapeutics.
  Rabenau K, Hofstatter E. Rabenau K, et al. Clin Ther. 2016 Jul;38(7):1577-88. doi: 10.1016/j.clinthera.2016.06.006. Epub 2016 Jun 29. Clin Ther. 2016. PMID: 27368114 Review.

Cited by

• Crosstalk between O-GlcNAcylation and ubiquitination: a novel strategy for overcoming cancer therapeutic resistance.
  Sun K, Zhi Y, Ren W, Li S, Zheng J, Gao L, Zhi K. Sun K, et al. Exp Hematol Oncol. 2024 Nov 1;13(1):107. doi: 10.1186/s40164-024-00569-5. Exp Hematol Oncol. 2024. PMID: 39487556 Free PMC article. Review.
• Association of ERCC1 Gene Polymorphisms (rs3212986 and rs11615) With the Risk of Lung Cancer in a Population From Southeast Iran.
  Khalouei A, Masoumi-Ardakani Y, Jafarzaheh A, Kalantari Khandani B, Sedghy F, Khosravi Mashizi A, Yaghoobi MM, Zangouey M, Shahouzehi B. Khalouei A, et al. J Res Health Sci. 2024 Sep 30;24(4):e00631. doi: 10.34172/jrhs.2024.166. Epub 2024 Sep 30. J Res Health Sci. 2024. PMID: 39431656 Free PMC article.
• Therapeutic upregulation of DNA repair pathways: strategies and small molecule activators.
  Song J, Park C, Cabanting FEB, Jun YW. Song J, et al. RSC Med Chem. 2024 Oct 11. doi: 10.1039/d4md00673a. Online ahead of print. RSC Med Chem. 2024. PMID: 39430950 Free PMC article. Review.
• Identification of BBC3 as a novel indicator for predicting prostate cancer development and olaparib resistance.
  Ma J, Qin X, Le W, Chen X, Wang X, Xu C. Ma J, et al. Discov Oncol. 2024 Sep 27;15(1):496. doi: 10.1007/s12672-024-01373-7. Discov Oncol. 2024. PMID: 39331229 Free PMC article.
• Inhibition of HDAC8 mitigates AKI by reducing DNA damage and promoting homologous recombination repair.
  Wang Y, Yu C, Yu J, Shen F, Du X, Liu N, Zhuang S. Wang Y, et al. J Cell Mol Med. 2024 Sep;28(18):e70114. doi: 10.1111/jcmm.70114. J Cell Mol Med. 2024. PMID: 39317961 Free PMC article.

References

1. 1. Science. 1997 Nov 7;278(5340):1064-8 - PubMed
2. 1. Cell. 2011 Mar 4;144(5):646-74 - PubMed
3. 1. Cancer Cell. 2011 May 17;19(5):664-78 - PubMed
4. 1. Nature. 2005 Apr 14;434(7035):917-21 - PubMed
5. 1. Genetics. 1968 May;59(1):37-44 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Guide to Pharmacology